{"id":985,"date":"2026-04-15T12:54:18","date_gmt":"2026-04-15T12:54:18","guid":{"rendered":"https:\/\/citations.tools.bio-logic.fr\/?p=985"},"modified":"2026-04-15T12:54:18","modified_gmt":"2026-04-15T12:54:18","slug":"on-the-corner-of-models-and-cure-gene-editing-in-cystic-fibrosis","status":"publish","type":"post","link":"https:\/\/citations.tools.bio-logic.fr\/?p=985","title":{"rendered":"On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis"},"content":{"rendered":"<h4>DOI:<\/h4>\n<p><a href=\"https:\/\/doi.org\/10.3389\/fphar.2021.662110\" target=\"_blank\" rel=\"noopener\">10.3389\/fphar.2021.662110<\/a><\/p>\n<h4>Authors:<\/h4>\n<p>M. Ensinck, Ang\u00e9lique Mottais, Claire Detry, Teresinha Leal, Marianne Carlon<\/p>\n<h4>Abstract:<\/h4>\n<p>Cystic fibrosis (CF) is a severe genetic disease for which curative treatment is still lacking. Next generation biotechnologies and more efficient cell-based and <i>in vivo<\/i> disease models are accelerating the development of novel therapies for CF. Gene editing tools, like CRISPR-based systems, can be used to make targeted modifications in the genome, allowing to correct mutations directly in the Cystic Fibrosis Transmembrane conductance Regulator (<i>CFTR<\/i>) gene. Alternatively, with these tools more relevant disease models can be generated, which in turn will be invaluable to evaluate novel gene editing-based therapies for CF. This critical review offers a comprehensive description of currently available tools for genome editing, and the cell and animal models which are available to evaluate them. Next, we will give an extensive overview of proof-of-concept applications of gene editing in the field of CF. Finally, we will touch upon the challenges that need to be addressed before these proof-of-concept studies can be translated towards a therapy for people with CF.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DOI: 10.3389\/fphar.2021.662110 Authors: M. Ensinck, Ang\u00e9lique Mottais, Claire Detry, Teresinha Leal, Marianne Carlon Abstract: Cystic fibrosis (CF) is a severe genetic disease for which curative treatment is still lacking. Next generation biotechnologies and more efficient cell-based and in vivo disease models are accelerating the development of novel therapies for CF. Gene editing tools, like CRISPR-based [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-985","post","type-post","status-publish","format-standard","hentry","category-m470-leis"],"_links":{"self":[{"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=\/wp\/v2\/posts\/985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=985"}],"version-history":[{"count":0,"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=\/wp\/v2\/posts\/985\/revisions"}],"wp:attachment":[{"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=985"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=985"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/citations.tools.bio-logic.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}